The normalization of IgD-CD27- B cells in peripheral blood after treatment with TNF-inhibitors and tocilizumab might suggest a relevant role of these B cells in RA pathogenesis either through T cell activation, cytokine release and/ or antibody production. The gene discussed is CD27; the disease is rheumatoid arthritis.